Search the Newsroom
Filter By
Showing 701 - 710 of 2907 results
CHOP-led Study Identifies Two Different Regulatory T Cell Populations
A CHOP-led study has shown that a regulatory class of T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity.
CHOP Researchers Use Novel Technique to Analyze 53 Million Points of Clinical Data
Findings demonstrate how a new computational method could effectively analyze phenotypes and identify similarities among patient populations.
CHOP Researchers Reveal Complex Assembly Process Involved in DNA Virus Replication
CHOP researchers have shown that adenovirus proteins use a process called phase separation to coordinate production of viral progeny, which could have broad implications.
Feature Article: How Many Trivia Questions About Vaccine Ingredients Can You Answer?
Have fun with this trivia related to vaccines and their ingredients.
Vaccine News & Notes — April 2023
Get details about the Hilleman essay contest for students in grades 6 through 12, and review the science on two "controversies" surrounding COVID-19: masks and lab leak.
Children’s Hospital of Philadelphia Receives $10 Million Grant from the Gilbert Family Foundation to Accelerate Neurofibromatosis Research
Children’s Hospital of Philadelphia (CHOP) today announced that it has received more than $10 million in a series of gifts to fund critical neurofibromatosis research from the Gilbert Family Foundation, a private foundation established by Dan and Jennifer Gilbert to accelerate a cure for neurofibromatosis type 1 (NF1).
For Third Year in a Row, CHOP Fetal Program Wins Award for Excellence in Patient and Family Experience
The Richard D. Wood Jr. Center for Fetal Diagnosis and Treatment (CFDT) at Children’s Hospital of Philadelphia (CHOP) has again won an award from Press Ganey, a healthcare company that evaluates patient satisfaction.
Children’s Hospital of Philadelphia President and CEO Releases New Podcast Season
"The Breakthrough Chronicles” highlights the inspiring stories of CHOP patients and families.
Researchers Show Lorlatinib is Safe, Effective for Patients with High-Risk Neuroblastoma
CHOP researchers have shown that adenovirus proteins use a process called phase separation to coordinate production of viral progeny, which could have broad implications.
Two Focal Lesions: Extra Rare Cases Not so Rare at CHOP
The Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia, with a high volume of approximately 80 congenital hyperinsulinism (HI) cases a year, sees a large share of unusual cases.